Phase III trial results revealed at Clinical Trials on Alzheimer's Disease conference in San Francisco.

Alzheimer's Society, study participant Eric Deeson and Sir Prof John Hardy comment on the disappointing clinical trial results for Alzheimer's drug gantenerumab.

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, comments on news surrounding breakthrough Alzheimer's drug lecanemab.

Alzheimer’s Society reveals most unforgettable moments on the pitch on England team’s 150th birthday.

Bill and Jo's Heart-breaking story illustrates how people with dementia ‘face being abandoned’ as care workers struggle to make ends meet.

Survey of nearly 2,000 people affected by dementia reveals less than half felt care staff had a good understanding of dementia and one in four didn’t feel at all involved in the planning of their care.